Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 yearsALSOP, Kathryn; MEAD, Leeanne; HOPPER, John L et al.European journal of cancer (1990). 2006, Vol 42, Num 10, pp 1357-1361, issn 0959-8049, 5 p.Article

Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in Patients With Metastatic, Chemotherapy-Refractory, Wild-Type K-RAS Colorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 TrialSIU, Lillian L; SHAPIRO, Jeremy D; NOTT, Louise M et al.Journal of clinical oncology. 2013, Vol 31, Num 19, pp 2477-2484, issn 0732-183X, 8 p.Article

Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanomaRANSON, Malcolm; HERSEY, Peter; BAKA, Sofia et al.Journal of clinical oncology. 2007, Vol 25, Num 18, pp 2540-2545, issn 0732-183X, 6 p.Article

Incidence of malignancies in heart and/or lung transplant recipients : A single-institution experienceROITHMAIER, Sabine; HAYDON, Andrew M; LOI, Sherene et al.The Journal of heart and lung transplantation. 2007, Vol 26, Num 8, pp 845-849, issn 1053-2498, 5 p.Article

Body size and composition and colon cancer risk in womenMACINNIS, Robert J; ENGLISH, Dallas R; HOPPER, John L et al.International journal of cancer. 2006, Vol 118, Num 6, pp 1496-1500, issn 0020-7136, 5 p.Article

Ethnicity and Risk for Colorectal Cancers Showing Somatic BRAF V600E Mutation or CpG Island Methylator PhenotypeENGLISH, Dallas R; YOUNG, Joanne P; ROBERTS, Aedan et al.Cancer epidemiology, biomarkers & prevention. 2008, Vol 17, Num 7, pp 1774-1780, issn 1055-9965, 7 p.Article